Literature DB >> 31939664

Computational Method for Structure-Based Analysis of SAR Transfer.

Davide Bonanni1,2, Marco L Lolli1, Jürgen Bajorath2.   

Abstract

The identification of different compound series with corresponding structure-activity relationship (SAR) progression for a given target is referred to as SAR transfer, which is of interest in lead optimization. If difficulties are encountered during multiproperty optimization, the SAR transfer concept can be applied attempting to replace a lead compound with another candidate. For a systematic assessment of SAR transfer, computational approaches are required. So far, SAR transfer has been investigated at the level of compounds and analogue series. Herein, we introduce a new computational method for structure-guided exploration of SAR transfer. The approach relies on a three-dimensional molecular fragmentation and recombination scheme and the identification of analogues of crystallographic ligands. On the basis of spatially aligned X-ray ligands, alternative substituents and compound cores are identified, enabling the detection of multiple SAR transfer events. Application of the methodology across different targets identified SAR transfer events with high frequency.

Entities:  

Year:  2020        PMID: 31939664     DOI: 10.1021/acs.jmedchem.9b01931

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety.

Authors:  Stefano Sainas; Marta Giorgis; Paola Circosta; Giulio Poli; Marta Alberti; Alice Passoni; Valentina Gaidano; Agnese C Pippione; Nicoletta Vitale; Davide Bonanni; Barbara Rolando; Alessandro Cignetti; Cristina Ramondetti; Alessia Lanno; Davide M Ferraris; Barbara Canepa; Barbara Buccinnà; Marco Piccinini; Menico Rizzi; Giuseppe Saglio; Salam Al-Karadaghi; Donatella Boschi; Riccardo Miggiano; Tiziano Tuccinardi; Marco L Lolli
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.